Providence Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
12,520
+2
| +0% | +$2.03K | 7.61% | 1 |
|
|
2025
Q4 | $13M | Sell |
12,518
-128
| -1% | -$122K | 8.13% | 1 |
|
|
2025
Q3 | $10.4M | Sell |
12,646
-15
| -0.1% | -$11.2K | 6.54% | 3 |
|
|
2025
Q2 | $8.09M | Sell |
12,661
-98
| -0.8% | -$76.2K | 5.55% | 3 |
|
|
2025
Q1 | $10.2M | Buy |
12,759
+289
| +2% | +$240K | 7.73% | 1 |
|
|
2024
Q4 | $9.55M | Sell |
12,470
-290
| -2% | -$240K | 7.23% | 2 |
|
|
2024
Q3 | $11.5M | Sell |
12,760
-26
| -0.2% | -$23.4K | 8.52% | 1 |
|
|
2024
Q2 | $11.7M | Buy |
12,786
+10
| +0.1% | +$8K | 9.31% | 1 |
|
|
2024
Q1 | $9.76M | Buy |
12,776
+10,393
| +436% | +$7.4M | 8.33% | 1 |
|
|
2023
Q4 | $1.1M | Sell |
2,383
-10,548
| -82% | -$6.16M | 0.99% | 32 |
|
|
2023
Q3 | $6.86M | Sell |
12,931
-24
| -0.2% | -$12.4K | 7.65% | 2 |
|
|
2023
Q2 | $6.03M | Sell |
12,955
-101
| -0.8% | -$42.4K | 6.68% | 3 |
|
|
2023
Q1 | $4.84M | Sell |
13,056
-394
| -3% | -$133K | 3.58% | 6 |
|
|
2022
Q4 | $4.82M | Sell |
13,450
-141
| -1% | -$50K | 3.58% | 7 |
|
|
2022
Q3 | $5.02M | Sell |
13,591
-622
| -4% | -$197K | 3.75% | 4 |
|
|
2022
Q2 | $4.66M | Buy |
14,213
+331
| +2% | +$99.4K | 3.36% | 7 |
|
|
2022
Q1 | $4.06M | Buy |
13,882
+30
| +0.2% | +$7.72K | 2.61% | 11 |
|
|
2021
Q4 | $3.57M | Sell |
13,852
-92
| -0.7% | -$23.3K | 2.25% | 12 |
|
|
2021
Q3 | $3.21M | Sell |
13,944
-591
| -4% | -$146K | 2.23% | 13 |
|
|
2021
Q2 | $3.4M | Sell |
14,535
-9
| -0.1% | -$1.81K | 2.32% | 13 |
|
|
2021
Q1 | $2.72M | Buy |
14,544
+138
| +1% | +$27K | 2% | 13 |
|
|
2020
Q4 | $2.41M | Sell |
14,406
-17
| -0.1% | -$2.54K | 2% | 13 |
|
|
2020
Q3 | $2.13M | Sell |
14,423
-165
| -1% | -$25.5K | 2.11% | 14 |
|
|
2020
Q2 | $2.4M | Buy |
14,588
+101
| +0.7% | +$15.5K | 2.44% | 9 |
|
|
2020
Q1 | $1.98M | Buy |
14,487
+23
| +0.2% | +$3.16K | 2.38% | 10 |
|
|
2019
Q4 | $1.9M | Sell |
14,464
-1,032
| -7% | -$120K | 1.74% | 17 |
|
|
2019
Q3 | $1.73M | Sell |
15,496
-40
| -0.3% | -$4.45K | 1.55% | 21 |
|
|
2019
Q2 | $1.75M | Sell |
15,536
-348
| -2% | -$41K | 1.63% | 19 |
|
|
2019
Q1 | $2.08M | Buy |
15,884
+196
| +1% | +$23.8K | 1.96% | 15 |
|
|
2018
Q4 | $1.79M | Sell |
15,688
-137
| -0.9% | -$15.3K | 1.99% | 14 |
|
|
2018
Q3 | $1.7M | Sell |
15,825
-107
| -0.7% | -$10.7K | 1.55% | 20 |
|
|
2018
Q2 | $1.36M | Sell |
15,932
-164
| -1% | -$13.5K | 1.32% | 27 |
|
|
2018
Q1 | $1.22M | Buy |
+16,096
| New | +$1.3M | 1.8% | 21 |
|
Other funds holding LLY
VCM
VPM
Providence Wealth Advisors's LLY Position: Q1 2026 in Review
Providence Wealth Advisors increased its Eli Lilly (LLY) stake by 0.02% in Q1 2026, buying an estimated $2.03K and bringing the position to 12,520 shares worth $12M. The position accounts for 7.61% of the portfolio, ranked #1.
Providence Wealth Advisors first reported a position in LLY in Q1 2018 and has held it in 33 quarters since. The position peaked at $13M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Providence Wealth Advisors held 12,520 shares of Eli Lilly worth $12M as of Q1 2026.
- Providence Wealth Advisors bought 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
- Eli Lilly made up 7.61% of Providence Wealth Advisors's portfolio in Q1 2026, its #1 holding.
- Providence Wealth Advisors first reported a position in Eli Lilly in Q1 2018 and has held it in 33 quarters since.
- Providence Wealth Advisors's Eli Lilly position peaked at $13M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Providence Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.